- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Suraksha Diagnostic Ltd (SURK)
Track today's live Suraksha Diagnostic (SURK) share price, performance and key data on this page with our current NSE:SURK stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Suraksha Diagnostic share price on the NSE exchange. Use the dropdown to switch exchange for the SURK share price, head to our technical summary section, which provides analysis on Suraksha Diagnostic share price buy/sell indicators using real-time data (or discuss the Suraksha Diagnostic (SURK) stock price today with other investors in the Suraksha Diagnostic NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE:SURK share price (ISIN: INE877V01027) to enhance your trading decisions with our free investment tools and resources.
What Is the Suraksha Diagnostic Ltd Share Price Today?
The Suraksha Diagnostic share price today is 252.15.
What Is the Stock Symbol for Suraksha Diagnostic Ltd
The stock symbol (or 'ticker') for Suraksha Diagnostic Ltd is "SURK."
What Stock Exchange Does Suraksha Diagnostic Ltd Trade On?
Suraksha Diagnostic Ltd is listed and trades on the NSE stock exchange.
Is Suraksha Diagnostic Ltd a Good Stock to Buy?
Determining whether Suraksha Diagnostic (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NSE:SURK share price (ISIN: INE877V01027) to enhance your trading decisions with our free investment tools and resources.
What Is the Suraksha Diagnostic Ltd Share Price Today?
The Suraksha Diagnostic share price today is 252.15.
What Is the Stock Symbol for Suraksha Diagnostic Ltd
The stock symbol (or 'ticker') for Suraksha Diagnostic Ltd is "SURK."
What Stock Exchange Does Suraksha Diagnostic Ltd Trade On?
Suraksha Diagnostic Ltd is listed and trades on the NSE stock exchange.
Is Suraksha Diagnostic Ltd a Good Stock to Buy?
Determining whether Suraksha Diagnostic (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
252.15
+5.05(+2.04%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
248.30
253.00
52 wk Range
224.10
333.00
Earnings results expected in 7 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
248.30253.00
52 wk Range
224.10333.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.20%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.20%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SURK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
285.00
Upside
+13.03%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 285.00
(+13.03% Upside)
Earnings
Latest Release
21/05/2026
EPS / Forecast
1.21 / --
Revenue / Forecast
814M / --
Compare SURK to Peers and Sector
Metrics to compare | SURK | Peers Peers - average of corresponding metrics from companies closely matching SURK: METROPOLIS, VIJAYA, MAXHEALTH, AGARWALEYE, CHANDAN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSURKPeersSector |
|---|---|---|---|---|
P/E Ratio | 40.0x | 54.6x | −0.3x | |
PEG Ratio | 11.54 | 0.80 | 0.00 | |
Price/Book | 5.3x | 6.2x | 2.6x | |
Price / LTM Sales | 4.1x | 6.2x | 3.0x | |
Upside (Analyst Target) | 13.6% | 5.7% | 56.6% | |
Fair Value Upside | Unlock | −4.5% | 10.2% | Unlock |
Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Suraksha Diagnostic (NSE: SURK) Share Price Today?
The Suraksha Diagnostic stock price today is 252.15 INR.
What Stock Exchange Does Suraksha Diagnostic (SURK) Trade On?
Suraksha Diagnostic is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Suraksha Diagnostic?
The stock symbol (also called a 'ticker') for Suraksha Diagnostic is "SURK."
Does Suraksha Diagnostic Pay Dividends? What’s The Current SURK Dividend Yield?
Yes, SURK Pays Dividends to its Shareholders. The current Suraksha Diagnostic dividend yield is 0.2%.
What Is the Current Suraksha Diagnostic Market Capitalisation?
As of today, Suraksha Diagnostic (NSE: SURK) market cap is 13.13B INR.
What Is Suraksha Diagnostic's (SURK) Earnings Per Share (TTM)?
The Suraksha Diagnostic EPS is currently 6.18 (Trailing Twelve Months).
When Is the Next Suraksha Diagnostic Earnings Date?
Suraksha Diagnostic's next earnings report will be released on 07/08/2026.
Is SURK a Buy or Sell From a Technical Analyst Perspective?
Based on today's Suraksha Diagnostic moving averages and other technical indicators, the daily buy/sell signal for SURK stock is Strong Sell.
How Many Times Has Suraksha Diagnostic Stock Split?
Suraksha Diagnostic has split 0 times. (See the SURK stock split history page for full effective split date and price information.)
How Many Employees Does Suraksha Diagnostic Have?
Suraksha Diagnostic has 1300 employees, based on their latest Companies House report.
What is the current trading status of Suraksha Diagnostic (NSE: SURK)?
As of 31/07/2026, Suraksha Diagnostic (SURK) is trading at a share price of 252.15 INR, with a previous close of 247.10 INR. The stock has fluctuated within a day range of 248.30 INR to 253.00 INR, while its 52-week range spans from 224.10 INR to 333.00 INR.
What Is Suraksha Diagnostic (SURK) Price Target According to Analysts?
The average 12-month price target for Suraksha Diagnostic is 285.00 INR, with a high estimate of 285 INR and a low estimate of 285 INR. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +13.03% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.